An online grief intervention to improve well-being and reduce clinical symptoms: a randomized controlled trial.
Saved in:
| Title: | An online grief intervention to improve well-being and reduce clinical symptoms: a randomized controlled trial. |
|---|---|
| Authors: | Dominguez-Rodriguez, Alejandro (AUTHOR), Herdoiza-Arroyo, Paulina Erika (AUTHOR), Sanz-Gómez, Sergio (AUTHOR), Albán-Terán, Margarita Gabriela (AUTHOR), Nieto Ramos, Emilia Gabriela (AUTHOR), Villavicencio Calderón, Emilia Nicole (AUTHOR), Casa Leiva, Alisson Nicole (AUTHOR), de la Rosa-Gómez, Anabel (AUTHOR), Arenas-Landgrave, Paulina (AUTHOR) |
| Source: | Death Studies. 2026, Vol. 50 Issue 2, p307-319. 13p. |
| Subjects: | Evaluation of medical care, Psychotherapy, Statistical power analysis, Pearson correlation (Statistics), Research funding, Data analysis, Statistical sampling, Questionnaires, Internet, Psychological well-being, Treatment effectiveness, Descriptive statistics, Randomized controlled trials, Mann Whitney U Test, Chi-squared test, Analysis of covariance, Statistics, Grief, Confidence intervals, Data analysis software, COVID-19 pandemic, Nonparametric statistics, Evaluation |
| Geographic Terms: | Mexico |
| Abstract: | The COVID-19 pandemic amplified the emotional impact of losing a loved one, deteriorating well-being, and increasing dysphoric symptoms in mourners. This study evaluated the efficacy of COVID Grief, a self-applied online cognitive-behavioral intervention for Mexican adults facing grief during the pandemic. We conducted a randomized clinical trial, enrolling 1,109 participants, 45 of whom completed the full intervention, and 69 of whom completed the waiting list control (WLC). Between-subject analysis showed that intervention group (IG) participants reported significantly higher satisfaction with life and quality of life and a reduction in depression, anxiety and stress levels compared to those in the WLC. Within-subjects analysis showed that IG presented no significant changes in satisfaction with life, whereas the quality of life was increased, and levels of depression, anxiety, and stress were reduced after treatment. For WLC, satisfaction with life and quality of life were significantly decreased, and symptoms of depression and anxiety -but not stress symptoms- increased after the waitlist. Completer's opinions of the treatment were highly positive, although they only represent 5% of participants who accessed the intervention. High dropout rates should be addressed in future studies. [ABSTRACT FROM AUTHOR] |
| Copyright of Death Studies is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | The COVID-19 pandemic amplified the emotional impact of losing a loved one, deteriorating well-being, and increasing dysphoric symptoms in mourners. This study evaluated the efficacy of COVID Grief, a self-applied online cognitive-behavioral intervention for Mexican adults facing grief during the pandemic. We conducted a randomized clinical trial, enrolling 1,109 participants, 45 of whom completed the full intervention, and 69 of whom completed the waiting list control (WLC). Between-subject analysis showed that intervention group (IG) participants reported significantly higher satisfaction with life and quality of life and a reduction in depression, anxiety and stress levels compared to those in the WLC. Within-subjects analysis showed that IG presented no significant changes in satisfaction with life, whereas the quality of life was increased, and levels of depression, anxiety, and stress were reduced after treatment. For WLC, satisfaction with life and quality of life were significantly decreased, and symptoms of depression and anxiety -but not stress symptoms- increased after the waitlist. Completer's opinions of the treatment were highly positive, although they only represent 5% of participants who accessed the intervention. High dropout rates should be addressed in future studies. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 07481187 |
| DOI: | 10.1080/07481187.2024.2421629 |
